Prediction markets now show Kamala Harris with a 3 percentage point lead on Donald Trump, according to Polymarket's prediction app.
All signs point to an incredibly close race with the election now 5 weeks out.
$Trump Media & Technology (DJT.US)$ $Kamala Harris (LIST22990.US)$ $Donald Trump (LIST22962.US)$
All signs point to an incredibly close race with the election now 5 weeks out.
$Trump Media & Technology (DJT.US)$ $Kamala Harris (LIST22990.US)$ $Donald Trump (LIST22962.US)$
2
7
frankinglily
liked
$UBS Group (UBS.US)$
Here are 10 companies positioned to benefit from this anticipated rise in investment 🧐
1. $ASML Holding (ASML.US)$ is the exclusive provider of EUV lithography technology, which is critical for fabricating chips below the 7 nm process node. This technology enables the creation of smaller, more energy-efficient chip...
Here are 10 companies positioned to benefit from this anticipated rise in investment 🧐
1. $ASML Holding (ASML.US)$ is the exclusive provider of EUV lithography technology, which is critical for fabricating chips below the 7 nm process node. This technology enables the creation of smaller, more energy-efficient chip...
26
frankinglily
liked
While I personally prefer buying $Micron Technology (MU.US)$ near book value (where it was merely a year ago), there are worse things than an oligopolistic growth cyclical delivering to an end-market in a boom phase
3
frankinglily
liked
The chart below displays some (but not all) of the key components used in calculating return on capital including the free cash flow (grey bars), property plant & equipment (green line) and goodwill (red line).
We are focusing only on these three because I would like to highlight a key question: will all of the recent capital investment pay off?
During the early 2000s, FCF regularly exceeded PPE an...
We are focusing only on these three because I would like to highlight a key question: will all of the recent capital investment pay off?
During the early 2000s, FCF regularly exceeded PPE an...
12
frankinglily
liked
Charlie Kawwas head of $Broadcom (AVGO.US)$ semis business was even more explicit and detailed on this today at GS, segmenting the AI accelerator mkt into three parts:
- Internet scale customers ( $Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ Bytedance Tencent): significant logic and value for these companies spending $10s of Bns all on internal infra to customize ASICs for own environments. AVGO can bring new XPUs to mkt in a year. Sees most of this mkt going to custom silicon in 5yrs.
- Hyperscale...
- Internet scale customers ( $Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ Bytedance Tencent): significant logic and value for these companies spending $10s of Bns all on internal infra to customize ASICs for own environments. AVGO can bring new XPUs to mkt in a year. Sees most of this mkt going to custom silicon in 5yrs.
- Hyperscale...
3
$NVIDIA (NVDA.US)$ REPORTS ON WEDNESDAY
ARE WE BULLISH OR BULLISH
....or bearish
I think they beat the $28B guide and raise. The big question here is on the raise because of the Blackwell delay but given $Super Micro Computer (SMCI.US)$ guidance and $Taiwan Semiconductor (TSM.US)$ monthly metrics, I don't think that will have the largest impact for Q3.
All eyes on Jensen.
ARE WE BULLISH OR BULLISH
....or bearish
I think they beat the $28B guide and raise. The big question here is on the raise because of the Blackwell delay but given $Super Micro Computer (SMCI.US)$ guidance and $Taiwan Semiconductor (TSM.US)$ monthly metrics, I don't think that will have the largest impact for Q3.
All eyes on Jensen.
5
1
frankinglily
liked
Argument:
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
5
1
$NVIDIA (NVDA.US)$ reclaimed the 10-week/50-day lines on a strong rebound. It gained 18.93% for the week and closed near the highs of the week after the prior week's undercut and rally off the prior base. It may be forming the right side of a new base (36% deep, 140.76 std pivot, 136.15 early pivot). See if it can follow-through next week and clear the descending trend line of its base. EPS on 8/28, AMC.
6